Higher dose of Gleevec leads to increased remission in CML patients

SAN DIEGO -- Twice the standard daily dose of Gleevec results in a significantly higher response rate in treatment of chronic myeloid leukemia (CML), according to researchers at The University of Texas M. D. Anderson Cancer Center.

The study, presented at the annual meeting of the American Society of Hematology (ASH), suggests that patients should routinely receive the higher dose regimen if additional studies continue to show such a dramatic benefit for patients.

"This is a relatively small study, but there is no question that patients who used higher doses of Gleevec clearly showed improvement compared with patients who used a standard dose," says Jorge Cortes, M.D., deputy chair in the Department of Leukemia. "We feel so comfortable with what we are finding that patients being treated at M. D. Anderson already are being given the higher dose therapy."

The study is the first to look at use of high-dose Gleevec in patients with newly diagnosed, early stage CML. Initial dose-escalating studies conducted with CML patients who had failed traditional interferon treatment suggested that patients treated with higher doses of the drug did well, even though a 400-milligram dose was "arbitrarily" selected as the standard, Cortes says.

The researchers compared results of two ongoing consecutive trials being conducted at M. D. Anderson, one using standard dose Gleevec, and the other testing the higher dose in newly diagnosed patients. They found that 18 months after treatment, 28 percent of 114 patients treated with 800 milligrams of Gleevec a day (using two 400 mg pills) had no molecular evidence of disease, compared with 7 percent of 50 patients who used the 400 mg daily dose.

The benefit increased over time. After 24 months, 48 percent of patients using two daily pills had no evidence of disease, compared to 17 percent of patients treated with one pill a day. Now 30 months into the studies, data are still being gathered.


Contact: Julie Penne
University of Texas M. D. Anderson Cancer Center

Page: 1 2

Related medicine news :

1. Higher folate intake associated with decreased risk of hypertension in women
2. Higher incidence of rejection following early steroid withdrawal
3. Higher radiation doses help some lung cancer patients live longer
4. Higher doses of cancer drug imatinib proven effective and safe
5. Higher education or larger brain size may protect against dementia later in life, new study finds
6. Higher cost sharing reduces plans drug expenditures, but boosts enrollee costs
7. Higher nocturnal blood pressure predictive of kidney disease in diabetes
8. First quarter 2002 prescription drug spending: Higher again, but rate of increase drops
9. Higher rate of improvement, lower rate of adverse effects with clarithromycin for acute exacerbations of chronic bronchitis
10. Cancer Rates In Children Of Nuclear Industry Employees No Higher Than General Population In England And Wales
11. New Study Finds Blacks Face 38 Percent Higher Stroke Risk

Post Your Comments:

(Date:6/3/2020)... (PRWEB) , ... June 03, 2020 , ... Principals of ... from February to March (39%) and from March to April (44%). To back this ... doubled from February to April. Revenue for the company has followed a similar trajectory, ...
(Date:5/30/2020)... ... , ... Worldwide Business with kathy ireland® will be LIVE streaming this ... 3, 2020 at 8:00pm ET / PT – two chances to watch each night! This ... and Diagnostic Solutions Laboratory . , As leaders in their industries, ...
(Date:5/28/2020)... , ... May 28, 2020 , ... ... organization is joining the clinically integrated network (CIN) and the group purchasing organization ... AHN’s Cardiovascular Institute to establish a heart failure program at Mon Health Medical ...
(Date:5/27/2020)... ... , ... The podiatrists and foot doctors of Advanced Foot & Ankle Specialists ... Ann Arbor Michigan. Dr. Tomasz Biernacki states that “Podiatrists can help support ... hospital. We have been seeing patients in the hospital for the past 3 months, ...
(Date:5/26/2020)... LIVONIA, Mich. (PRWEB) , ... ... ... and RevSpring today announced the availability of two leading RevSpring solutions—Talksoft® patient ... Loyale Patient Payment platform by engaging patients through automated and precise texts, ...
Breaking Medicine News(10 mins):
(Date:6/3/2020)... CLEARWATER, Fla. (PRWEB) , ... June 03, 2020 ... ... practice growth management, Progressive Dental Marketing provides guidance at the Dental ... “Group Dentistry in The NEW World: Sustaining and Thriving Going Forward.” Progressive ...
(Date:6/2/2020)... ... June 02, 2020 , ... As the ... in response to COVID-19 it is working with its corporate team, its consultants, ... reimbursements, and a host of digital resources. Harmony’s leadership team recognized the extraordinary ...
(Date:6/2/2020)... ... June 02, 2020 , ... Aniara Diagnostica, a multi-national ... its commitment to meeting today’s highest standards for product quality and cost-efficient delivery. ... stages of drug discovery, screening of chemical, cosmetic, alimentary, or agrochemical compounds, and ...
Breaking Medicine Technology:
Cached News: